Clinical Trial Update: A Multi-centre, Phase II, Double-blind, Randomised, Placebo-controlled, Parallel Group, Dose-ranging Study in Patients With Faecal Incontinence; to Evaluate the Efficacy, Safety and Tolerability of Locally Applied NRL001 Over an 8 Week Treatment Period [Phase 2]

View source ↗

Summary

Phase II, multicentre, double-blind, randomized, placebo-controlled, dose-ranging trial evaluating the efficacy, safety and tolerability of locally applied NRL0…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Faecal Incontinence

Drugs mentioned

• NRL001

Snippet

Sponsor: Norgine | Conditions: Faecal Incontinence | Phase 2 | Status: COMPLETED